查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1386414

大腸診斷市場報告：2030 年趨勢、預測與競爭分析

Colorectal Cancer Diagnostic Market Report: Trends, Forecast and Competitive Analysis to 2030
出版日期: | 出版商: Lucintel | 英文 150 Pages | 商品交期: 3個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

簡介目錄

大腸診斷的趨勢和預測

到 2030 年，全球大腸腸癌診斷市場預計將達到 56 億美元，2024 年至 2030 年年複合成長率為 8.5%。該市場的主要促進因素是癌症盛行率的增加、意識的提高和早期診斷治療以及醫療保健支出的增加。全球大腸直腸癌診斷市場的未來前景廣闊，醫院、診斷中心、癌症研究中心和門診手術中心市場存在商機。

大腸直腸癌診斷市場洞察

Lucintel 預測，由於癌症診斷的醫療保健支出增加以及對預防性護理的偏好增加，設備將在預測期內實現最高成長。

在這個市場中，由於對大腸疾病具有成本效益的診斷設施的需求不斷成長以及全球診斷中心數量的不斷增加，診斷中心仍然是最大的部分。

由於先進的診斷程序和技術的可用性以及對大腸診斷測試的需求不斷增加，預計北美在預測期內將出現最高的成長。

本報告回答了 11 個關鍵問題：

  • Q.1. 細分市場中最有前途和高成長的機會是什麼？
  • Q.2.哪個細分市場將以更快的速度成長？為什麼？
  • Q.3.您認為哪些地區未來會出現更快的成長？為什麼？
  • Q.4. 影響市場動態的主要因素有哪些？市場的主要挑戰和商業風險是什麼？
  • Q.5. 這個市場的商業風險和競爭威脅是什麼？
  • Q.6.這個市場有哪些新趨勢？為什麼？
  • Q.7.市場客戶需求有何改變？
  • Q.8. 該市場有哪些新發展以及哪些公司處於領先地位？
  • Q.9.這個市場的主要企業有哪些？主要企業採取哪些策略配合措施來發展業務？
  • Q.10. 該市場上的競爭產品有哪些？由於材料或產品替代而導致市場佔有率下降的威脅有多大？
  • Q.11.過去年度發生了哪些併購事件，對產業產生了哪些影響？

目錄

第1章 執行摘要

第2章 全球大腸直腸癌診斷市場：市場動態

  • 簡介、背景、分類
  • 供應鏈
  • 產業促進因素與挑戰

第3章 2018-2030年市場趨勢及預測分析

  • 宏觀經濟趨勢（2018-2023）與預測（2024-2030）
  • 全球大腸直腸癌診斷市場趨勢（2018-2023）與預測（2024-2030）
  • 按產品類型分類的全球大腸診斷市場
    • 裝置
    • 消耗品及配件
  • 按癌症類型分類的全球大腸診斷市場
    • 腺癌
    • 大腸淋巴瘤
    • 胃腸道基質腫瘤
    • 類癌瘤
    • 其他
  • 按年齡層別分類的全球大腸診斷市場
    • 老年人
    • 成人
    • 兒童
  • 全球大腸診斷市場（依最終用途）
    • 醫院
    • 診斷中心
    • 癌症研究中心
    • 門診手術中心
    • 其他

第4章 2018-2030年分地區市場趨勢及預測分析

  • 全球大腸診斷市場（按地區）
  • 北美大腸直腸癌診斷市場
  • 歐洲大腸直腸癌診斷市場
  • 亞太大腸診斷市場
  • 其他地區大腸直腸癌大腸市場

第5章 競爭分析

  • 產品系列分析
  • 營運整合
  • 波特五力分析

第6章 成長機會與策略分析

  • 成長機會分析
    • 按產品類型分類的全球大腸診斷市場成長機會
    • 按癌症類型分類的全球大腸診斷市場成長機會
    • 按年齡層別分類的全球大腸診斷市場的成長機會
    • 按最終用途分類的全球大腸診斷市場的成長機會
    • 全球大腸診斷市場按地區成長機會
  • 全球大腸直腸癌診斷市場新趨勢
  • 戰略分析
    • 新產品開發
    • 擴大全球大腸直腸癌診斷市場的產能
    • 全球大腸直腸癌診斷市場的合併、收購與合資企業
    • 認證和許可

第7章 主要企業概況

  • General Electric
  • Siemens Healthcare
  • Koninklijke Philips
  • F. Hoffmann-La Roche
  • Abbott
  • Illumina
  • QIAGEN
  • Thermo Fisher Scientific
  • Quest Diagnostics
  • Merck
簡介目錄

Colorectal Cancer Diagnostic Trends and Forecast

The future of the global colorectal cancer diagnostic market looks promising with opportunities in the hospital, diagnostic center, cancer research center, and ambulatory surgical center markets. The global colorectal cancer diagnostic market is expected to reach an estimated $5.6 billion by 2030 with a CAGR of 8.5% from 2024 to 2030. The major drivers for this market are increasing prevalence of cancer diseases, rising awareness and early diagnostic procedures, and increasing healthcare expenditure.

A more than 150-page report is developed to help in your business decisions.

Colorectal Cancer Diagnostic by Segment

The study includes a forecast for the global colorectal cancer diagnostic by product type, cancer type, age group, end use, and region.

Colorectal Cancer Diagnostic Market by Product Type [Shipment Analysis by Value from 2018 to 2030]:

  • Instruments
  • Consumables & Accessories

Colorectal Cancer Diagnostic Market by Cancer Type [Shipment Analysis by Value from 2018 to 2030]:

  • Adenocarcinoma
  • Colorectal Lymphoma
  • Gastrointestinal Stromal Tumors
  • Carcinoid Tumors
  • Others

Colorectal Cancer Diagnostic Market by Age Group [Shipment Analysis by Value from 2018 to 2030]:

  • Geriatric
  • Adults
  • Pediatric

Colorectal Cancer Diagnostic Market by End Use [Shipment Analysis by Value from 2018 to 2030]:

  • Hospitals
  • Diagnostic Centers
  • Cancer Research Centers
  • Ambulatory Surgical Centers
  • Others

Colorectal Cancer Diagnostic Market by Region [Shipment Analysis by Value from 2018 to 2030]:

  • North America
  • Europe
  • Asia Pacific
  • The Rest of the World

List of Colorectal Cancer Diagnostic Companies

Companies in the market compete on the basis of product quality offered. Major players in this market focus on expanding their manufacturing facilities, R&D investments, infrastructural development, and leverage integration opportunities across the value chain. With these strategies colorectal cancer diagnostic companies cater increasing demand, ensure competitive effectiveness, develop innovative products & technologies, reduce production costs, and expand their customer base. Some of the colorectal cancer diagnostic companies profiled in this report include-

  • General Electric
  • Siemens Healthcare
  • Koninklijke Philips
  • F. Hoffmann-La Roche
  • Abbott
  • Illumina
  • Qiagen
  • Thermo Fisher Scientific
  • Quest Diagnostics
  • Merck

Colorectal Cancer Diagnostic Market Insights

Lucintel forecasts that instruments is expected to witness highest growth over the forecast period due to the growing healthcare expenditure for cancer diagnosis and increasing preference for preventive healthcare measures.

Within this market, diagnostic centers will remain the largest segment due to growing need for cost effective diagnosis facilities for colorectal cancer disease and rising number of diagnostic centers globally.

North America is expected to witness highest growth over the forecast period due to availability of advanced diagnostic procedure and techniques and growing demand for colorectal cancer diagnostics testing.

Features of the Global Colorectal Cancer Diagnostic Market

Market Size Estimates: Colorectal cancer diagnostic market size estimation in terms of value ($B).

Trend and Forecast Analysis: Market trends (2018 to 2023) and forecast (2024 to 2030) by various segments and regions.

Segmentation Analysis: Colorectal cancer diagnostic market size by various segments, such as by product type, cancer type, age group, end use, and region in terms of ($B).

Regional Analysis: Colorectal cancer diagnostic market breakdown by North America, Europe, Asia Pacific, and Rest of the World.

Growth Opportunities: Analysis of growth opportunities in different product types, cancer types, age groups, end uses, and regions for the colorectal cancer diagnostic market.

Strategic Analysis: This includes M&A, new product development, and competitive landscape of the colorectal cancer diagnostic market.

Analysis of competitive intensity of the industry based on Porter's Five Forces model.

FAQ

Q.1 What is the colorectal cancer diagnostic market size?

Answer: The global colorectal cancer diagnostic market is expected to reach an estimated $5.6 billion by 2030.

Q.2 What is the growth forecast for colorectal cancer diagnostic market?

Answer: The global colorectal cancer diagnostic market is expected to grow with a CAGR of 8.5% from 2024 to 2030.

Q.3 What are the major drivers influencing the growth of the colorectal cancer diagnostic market?

Answer: The major drivers for this market are increasing prevalence of cancer diseases, rising awareness and early diagnostic procedures and increasing healthcare expenditure.

Q4. What are the major segments for colorectal cancer diagnostic market?

Answer: The future of the colorectal cancer diagnostic market looks promising with opportunities in the hospital, diagnostic center, cancer research center, and ambulatory surgical center markets.

Q5. Who are the key colorectal cancer diagnostic market companies?

Answer: Some of the key colorectal cancer diagnostic companies are as follows:

  • General Electric
  • Siemens Healthcare
  • Koninklijke Philips
  • F. Hoffmann-La Roche
  • Abbott
  • Illumina
  • Qiagen
  • Thermo Fisher Scientific
  • Quest Diagnostics
  • Merck

Q6. Which colorectal cancer diagnostic market segment will be the largest in future?

Answer: Lucintel forecasts that instruments is expected to witness highest growth over the forecast period due to the growing healthcare expenditure for cancer diagnosis and increasing preference for preventive healthcare measures.

Q7. In colorectal cancer diagnostic market, which region is expected to be the largest in next 5 years?

Answer: North America is expected to witness highest growth over the forecast period due to availability of advanced diagnostic procedure and techniques and growing demand for colorectal cancer diagnostics testing.

Q.8 Do we receive customization in this report?

Answer: Yes, Lucintel provides 10% customization without any additional cost.

This report answers following 11 key questions:

  • Q.1. What are some of the most promising, high-growth opportunities for the colorectal cancer diagnostic market by product type (instruments and consumables & accessories), cancer type (adenocarcinoma, colorectal lymphoma, gastrointestinal stromal tumors, carcinoid tumors, and others), age group (geriatric, adults, and pediatric), end use (hospitals, diagnostic centers, cancer research centers, ambulatory surgical centers, and others), and region (North America, Europe, Asia Pacific, and the Rest of the World)?
  • Q.2. Which segments will grow at a faster pace and why?
  • Q.3. Which region will grow at a faster pace and why?
  • Q.4. What are the key factors affecting market dynamics? What are the key challenges and business risks in this market?
  • Q.5. What are the business risks and competitive threats in this market?
  • Q.6. What are the emerging trends in this market and the reasons behind them?
  • Q.7. What are some of the changing demands of customers in the market?
  • Q.8. What are the new developments in the market? Which companies are leading these developments?
  • Q.9. Who are the major players in this market? What strategic initiatives are key players pursuing for business growth?
  • Q.10. What are some of the competing products in this market and how big of a threat do they pose for loss of market share by material or product substitution?
  • Q.11. What M&A activity has occurred in the last 5 years and what has its impact been on the industry?

Table of Contents

1. Executive Summary

2. Global Colorectal Cancer Diagnostic Market : Market Dynamics

  • 2.1: Introduction, Background, and Classifications
  • 2.2: Supply Chain
  • 2.3: Industry Drivers and Challenges

3. Market Trends and Forecast Analysis from 2018 to 2030

  • 3.1. Macroeconomic Trends (2018-2023) and Forecast (2024-2030)
  • 3.2. Global Colorectal Cancer Diagnostic Market Trends (2018-2023) and Forecast (2024-2030)
  • 3.3: Global Colorectal Cancer Diagnostic Market by Product Type
    • 3.3.1: Instruments
    • 3.3.2: Consumables & Accessories
  • 3.4: Global Colorectal Cancer Diagnostic Market by Cancer Type
    • 3.4.1: Adenocarcinoma
    • 3.4.2: Colorectal Lymphoma
    • 3.4.3: Gastrointestinal Stromal Tumors
    • 3.4.4: Carcinoid Tumors
    • 3.4.5: Others
  • 3.5: Global Colorectal Cancer Diagnostic Market by Age Group
    • 3.5.1: Geriatric
    • 3.5.2: Adults
    • 3.5.3: Pediatric
  • 3.6: Global Colorectal Cancer Diagnostic Market by End Use
    • 3.6.1: Hospitals
    • 3.6.2: Diagnostic Centers
    • 3.6.3: Cancer Research Centers
    • 3.6.4: Ambulatory Surgical Centers
    • 3.6.5: Others

4. Market Trends and Forecast Analysis by Region from 2018 to 2030

  • 4.1: Global Colorectal Cancer Diagnostic Market by Region
  • 4.2: North American Colorectal Cancer Diagnostic Market
    • 4.2.2: North American Colorectal Cancer Diagnostic Market by End Use: Hospitals, Diagnostic Centers, Cancer Research Centers, Ambulatory Surgical Centers, and Others
  • 4.3: European Colorectal Cancer Diagnostic Market
    • 4.3.1: European Colorectal Cancer Diagnostic Market by Product Type: Instruments and Consumables & Accessories
    • 4.3.2: European Colorectal Cancer Diagnostic Market by End Use: Hospitals, Diagnostic Centers, Cancer Research Centers, Ambulatory Surgical Centers, and Others
  • 4.4: APAC Colorectal Cancer Diagnostic Market
    • 4.4.1: APAC Colorectal Cancer Diagnostic Market by Product Type: Instruments and Consumables & Accessories
    • 4.4.2: APAC Colorectal Cancer Diagnostic Market by End Use: Hospitals, Diagnostic Centers, Cancer Research Centers, Ambulatory Surgical Centers, and Others
  • 4.5: ROW Colorectal Cancer Diagnostic Market
    • 4.5.1: ROW Colorectal Cancer Diagnostic Market by Product Type: Instruments and Consumables & Accessories
    • 4.5.2: ROW Colorectal Cancer Diagnostic Market by End Use: Hospitals, Diagnostic Centers, Cancer Research Centers, Ambulatory Surgical Centers, and Others

5. Competitor Analysis

  • 5.1: Product Portfolio Analysis
  • 5.2: Operational Integration
  • 5.3: Porter's Five Forces Analysis

6. Growth Opportunities and Strategic Analysis

  • 6.1: Growth Opportunity Analysis
    • 6.1.1: Growth Opportunities for the Global Colorectal Cancer Diagnostic Market by Product Type
    • 6.1.2: Growth Opportunities for the Global Colorectal Cancer Diagnostic Market by Cancer Type
    • 6.1.3: Growth Opportunities for the Global Colorectal Cancer Diagnostic Market by Age Group
    • 6.1.4: Growth Opportunities for the Global Colorectal Cancer Diagnostic Market by End Use
    • 6.1.5: Growth Opportunities for the Global Colorectal Cancer Diagnostic Market by Region
  • 6.2: Emerging Trends in the Global Colorectal Cancer Diagnostic Market
  • 6.3: Strategic Analysis
    • 6.3.1: New Product Development
    • 6.3.2: Capacity Expansion of the Global Colorectal Cancer Diagnostic Market
    • 6.3.3: Mergers, Acquisitions, and Joint Ventures in the Global Colorectal Cancer Diagnostic Market
    • 6.3.4: Certification and Licensing

7. Company Profiles of Leading Players

  • 7.1: General Electric
  • 7.2: Siemens Healthcare
  • 7.3: Koninklijke Philips
  • 7.4: F. Hoffmann-La Roche
  • 7.5: Abbott
  • 7.6: Illumina
  • 7.7: QIAGEN
  • 7.8: Thermo Fisher Scientific
  • 7.9: Quest Diagnostics
  • 7.10: Merck